TRICOR

This brand name is authorized in Croatia, Japan, United States, South Africa

Active ingredients

The drug TRICOR contains one active pharmaceutical ingredient (API):

1 Fenofibrate UNII U202363UOS - FENOFIBRATE

Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type α (PPARα). Through activation of PPARα, fenofibrate increases lipolysis and elimination of atherogenic triglyceride rich particles from plasma by activating lipoprotein lipase and reducing production of Apoprotein C-III. Read about Fenofibrate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRICOR Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AB05	Fenofibrate	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AB Fibrates
Discover more medicines within C10AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-399248813, HR-H-782085853
Country: JP	医薬品医療機器総合機構	Identifier(s): 2183006F3031, 2183006F4038
Country: US	FDA, National Drug Code	Identifier(s): 0074-3173, 0074-3189, 43353-272
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/7.5/0848